Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

19.10.17	Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2017 (PR Newswire)
18.10.17	Johnson & Johnson Wins Reversal Of First St. Louis Talc-Cancer Verdict (RTTNews)
17.10.17	Johnson & Johnson Lifts FY17 Forecast As Q3 Results Top Estimates (RTTNews)
17.10.17	Johnson & Johnson Q3 Income Rises 11% (RTTNews)
17.10.17	Johnson & Johnson Reports 2017 Third-Quarter Results: (PR Newswire)
12.10.17	Treasure Investments Corporation Releases Scripophily and Americana Currency Collections for Auctions (PR Newswire)
11.10.17	Johnson & Johnson Posting Notable Gain After Upgrade By Jefferies (RTTNews)
02.10.17	Johnson & Johnson Announces Completion of Codman Neurosurgery Divestiture to Integra LifeSciences Holding Corporation (PR Newswire)
29.09.17	Biotech Stocks Facing FDA Decision In October (RTTNews)
21.09.17	FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ (RTTNews)
20.09.17	PFE Claims J&J Engaged In Unlawful Conduct To Stifle Competition From Inflectra (RTTNews)
18.09.17	Q2 2017 S&P 500 Buybacks Fall 9.8% from Q1, to $120.1 Billion (PR Newswire)
14.09.17	Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results (PR Newswire)
13.09.17	Johnson & Johnson Launches Dr. Paul Janssen Project to Catalyze and Convene Champions of Science Across Generations and Geographies (PR Newswire)
13.09.17	Breakfast Technical Briefing on Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson (PR Newswire)
11.09.17	Integra LifeSciences To Sell Certain Neurosurgery Assets To Natus Medical (RTTNews)
11.09.17	Medivir Stock Down As Janssen To Discontinue Development Of JNJ-4178 (RTTNews)
11.09.17	Johnson & Johnson Consumer Inc. Debuts New Scientific Data at the European Academy of Dermatology and Venerology Annual Meeting (PR Newswire)
11.09.17	Johnson & Johnson Consumer Inc. präsentiert auf der Jahrestagung der European Academy of Dermatology and Venereology neue wissenschaftliche Daten (PR Newswire)
11.09.17	Johnson & Johnson Consumer Inc. présente de nouvelles données scientifiques lors du Congrès annuel de l'Académie européen de dermatologie et de vénéréologie (PR Newswire)
05.09.17	National Awards Program Seeking North Carolina's Top Youth Volunteers Of 2018 (PR Newswire)
29.08.17	Biotech Stocks Facing FDA Decision In September (RTTNews)
25.08.17	Florida Execution Using New Anesthetic Drug Turns Controversial (RTTNews)
21.08.17	JNJ To Pay Dearly For Talc-cancer Connection (RTTNews)
14.08.17	Johnson & Johnson to Participate in 2017 Morgan Stanley Global Health Care Conference (PR Newswire)
10.08.17	Technical Snapshots for These Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson (PR Newswire)
04.08.17	Johnson & Johnson to Participate in the 2017 Wells Fargo 12th Annual Healthcare Conference (PR Newswire)
04.08.17	Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference (PR Newswire)
03.08.17	FDA Panel Snubs JNJ, CHMP Seeks More Data From PBYI, TBPH On Watch, AGRX Slumps (RTTNews)
25.07.17	Report: More than 15,000 Adverse Events Linked to Xarelto in 2016 (PR Newswire)
18.07.17	Johnson & Johnson Q2 Profit Down, But Adj. EPS Tops View; Lifts 2017 Outlook (RTTNews)
18.07.17	Genmab To Receive Royalties On DARZALEX Sales From Janssen Biotech - Quick Facts (RTTNews)
18.07.17	Johnson & Johnson Q2 Earnings Rise 3% (RTTNews)
18.07.17	Johnson & Johnson Reports 2017 Second-Quarter Results: (PR Newswire)
14.07.17	Affinion Group, Inc. to Hold Informational Call to Discuss Results for the Quarter Ended June 30, 2017 (PR Newswire)
14.07.17	FDA Oks Janssen' Tremfya To Treat Moderate To Severe Plaque Psoriasis (RTTNews)
08.07.17	Commercial Hydrogen Announces New Board Member (PR Newswire)
26.06.17	Breakfast Technical Briefing on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson (PR Newswire)
22.06.17	Johnson & Johnson Releases 2016 Health for Humanity Report (PR Newswire)
21.06.17	S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017 (PR Newswire)
20.06.17	Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results (PR Newswire)
20.06.17	Douglas Wallace, Ph.D., Wins 2017 Dr. Paul Janssen Award for Biomedical Research (PR Newswire)
16.06.17	Johnson & Johnson Closes Acquisition Of Actelion (RTTNews)
13.06.17	J&J And Bayer Win Second Trial On Xarelto Bleeding Risks (RTTNews)
09.06.17	Johnson & Johnson Announces Expected Settlement of Actelion Tender Offer on June 16, 2017 (PR Newswire)
02.06.17	State Sues Big Pharma For Opioid Carnage (RTTNews)
25.05.17	Johnson & Johnson to Participate in the Goldman Sachs 38th Annual Global Healthcare Conference (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

08:39		Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen
27.12.24		Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus
27.12.24		BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
27.12.24		Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag
27.12.24		Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste
27.12.24		Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

08:39

Novartis-Aktie: Novartis muss sich erneut Schmiergeld-Vorwürfen stellen

27.12.24

Anleger in New York halten sich zurück: Dow Jones beendet die Freitagssitzung im Minus

27.12.24

BioNTech und Pfizer zahlen Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester

27.12.24

Dow Jones aktuell: Dow Jones verliert am Freitagnachmittag

27.12.24

Schwacher Wochentag in New York: Dow Jones verbucht am Freitagmittag Verluste

27.12.24

Börse Europa: Euro STOXX 50 verbucht zum Ende des Freitagshandels Zuschläge

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu Johnson & Johnson

Aktien Top/Flop

Johnson & Johnson Peer Group Nachrichten

Meistgelesene Nachrichten